Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Extensive Stage Lung Small Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00375193
What this trial is testing

Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy

Who this might be right for
Small Cell Lung Cancer
Celgene 75
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Testing effectiveness (Phase 2)Active Not RecruitingNCT03672773
What this trial is testing

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Recurrent Extensive Stage Small Cell Lung CarcinomaRefractory Extensive Stage Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer Center 35
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06780137
What this trial is testing

Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 327
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06227546
What this trial is testing

MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Georgetown University 9
Testing effectiveness (Phase 2)UnknownNCT00014547
What this trial is testing

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Lung Cancer
Theradex
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Testing effectiveness (Phase 2)UnknownNCT05975944
What this trial is testing

Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00282022
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals 87
Testing effectiveness (Phase 2)Ended earlyNCT05027867
What this trial is testing

KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Small-cell Lung CancerSmall Cell Lung CarcinomaSmall Cell Lung Cancer Extensive Stage+1 more
Kartos Therapeutics, Inc. 3
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Looking for participantsNCT07480213
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCSCLC, Extensive Stage
Beijing Biotech 60
Testing effectiveness (Phase 2)Looking for participantsNCT05882058
What this trial is testing

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Who this might be right for
Small Cell Lung CarcinomaNeuroendocrine NeoplasmsExtra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim 204
Early research (Phase 1)UnknownNCT05507593
What this trial is testing

Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Tianjin Medical University Cancer Institute and Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT07325136
What this trial is testing

Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Relapsed/Refractory Small Cell Lung Cancer
Bristol-Myers Squibb 240
Next Page